Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

NCI Experimental Therapeutics Program (NExT)

The NExT Program supports promising new drug discovery projects through the Chemical Biology Consortium, and small molecule and biologic drug development.

NExT is seeking applications for innovative and promising therapeutic modalities for new oncology targets in cancer therapy.  Applicants with treatment approaches and targets that are well documented are still encouraged to apply. However, priority is given to targets with unmet need and rare tumor indications.

The NExT application submission cycles occur on an ad hoc* basis, with the application submissions done using Proposal Central (registration required).

The application cycle submission deadline is 5:00 PM Eastern Time on the close date, even when the close date is on a weekend or holiday.

*There are no future dates scheduled for open NExT application cycles beyond the current cycle. Please continue to check this website for updates.

Open Date

Close Date

Late submissions cannot be accepted

July 15thAugust 15th

 

About the NExT Program

Email